UK markets closed
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,475.92 +268.82 (+1.48%) CRUDE OIL
78.23 +0.12 (+0.15%) GOLD FUTURES
2,302.60 -6.00 (-0.26%) DOW
38,675.68 +449.98 (+1.18%) Bitcoin GBP
51,216.57 +180.15 (+0.35%)
MyMD Pharmaceuticals, Inc. (MYMD)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.18M |
| Enterprise value | 2.46M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.59 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.15 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.17 |
| 52-week change 3 | -94.30% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 70.5000 |
| 52-week low 3 | 2.0000 |
| 50-day moving average 3 | 2.8146 |
| 200-day moving average 3 | 12.6531 |
Share statistics
| Avg vol (3-month) 3 | 231.48k |
| Avg vol (10-day) 3 | 53.66k |
| Shares outstanding 5 | 2.16M |
| Implied shares outstanding 6 | 2.16M |
| Float 8 | 1.93M |
| % held by insiders 1 | 7.32% |
| % held by institutions 1 | 9.45% |
| Shares short (15 Apr 2024) 4 | 393k |
| Short ratio (15 Apr 2024) 4 | 0.68 |
| Short % of float (15 Apr 2024) 4 | 18.21% |
| Short % of shares outstanding (15 Apr 2024) 4 | 18.21% |
| Shares short (prior month 15 Mar 2024) 4 | 93.38k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 25 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 15 Feb 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -57.77% |
| Return on equity (ttm) | -29.12% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -8.22M |
| Diluted EPS (ttm) | -5.3300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.92M |
| Total cash per share (mrq) | 2.28 |
| Total debt (mrq) | 48.87k |
| Total debt/equity (mrq) | 0.38% |
| Current ratio (mrq) | 1.17 |
| Book value per share (mrq) | 6.05 |
Cash flow statement
| Operating cash flow (ttm) | -12.98M |
| Levered free cash flow (ttm) | -5.27M |
© 2024 Yahoo. All rights reserved.